It is projected that by 2035, the number of people in the US over the age of 65 years old will be greater than the number of people below 18 years old. This projection illustrates the massive shift in the United States to an aged population. With the aging population comes challenges because of the increase costs and burdens of the diseases that accumulate with age. In our lab, we study the aging process in order to understand how to make people age slower. Our goal is not to make it possible to live 150 years, but rather to extend the period spent free of disease. In other words, rather than increase the lifespan, we aim to increase the healthspan. Of particular interest to our lab is how to maintain muscle, which is important for maintaining independence and a healthy metabolism.
In our laboratory we use models that live longer than they should, to understand what gives rise to increased healthspan. We focus on how to maintain proteins in a “young” state so that cells and tissues can continue to function normally and absent of disease. Of particular interest are mitochondria since these cellular organelles seem to be central to the aging process. Our research seeks to determine if we can maintain the quality of proteins in mitochondria to maintain overall health. In a tissue like muscle, it is our hope that maintaining mitochondria will help preserve muscle function with age. Importantly, it is always our goal to take what we learn in our laboratory experiments and translate them into human treatments that improve human healthspan.
Maintaining proteostasis with aging: The Geroscience Initiative identified proteostasis as one of the seven “pillars” of aging research. Proteostasis refers to the processes that maintain proteome fidelity. My research focuses on the biosynthesis and turnover components of proteostasis. In this regard, we make direct measures of these dynamic processes, not markers or indicators, which has led to important insight into shared characteristics of slowed aging. By using stable isotopes to simultaneously measure both protein synthesis and DNA synthesis in vitro and in vivo we have made two discoveries: 1) mitochondrial proteins are selectively translated in slowed aging models, and 2) when accounting for cell proliferation, the turnover of proteins in existing cells is increased, not decreased. These findings are repeatable in several slowed aging models and slowed aging treatments.
Translation of treatments to slow aging: It is my goal to translate our more basic science into potential human treatments to slow aging. We do this using unique animal models and with clinical trials in humans. My work in humans has focused either on exercise, metformin, or Nrf2 activation. More specifically, we have investigated the efficacy of these treatments to slow age-related declines in skeletal muscle mitochondrial function and skeletal muscle mass. For example, some in the aging field are pushing metformin to be the first drug used to treat aging. We have data both in support and against such use. It is clear to us that the field needs more evidence before pushing such an expensive clinical trial.
Approaches: Stable isotopes and mass spec are key features of my research program. In this regard, I consider our lab a leader in the use of D2O to measure in vitro and in vivo biosynthetic processes. We are working on methods to expand these approaches in order to continue to improve measurements of kinetic processes. I also have extensive experience in using stable isotopes for the assessment of metabolic flux. In combination these approaches allow us to explore the interface between protein and energetics.
B.S., Kinesiology, University of Wisconsin, Madison, WI, 1995
M.S., Kinesiology, University of Wisconsin, Madison, WI, 1998
Ph.D., Integrative Biology, University of California, Berkeley, CA, 2002
Honors and Awards
American Physiological Society Young Investigator Award, Environmental and Exercise Physiology, Washington, DC, 2004
American Physiological Society Journals Star Reviewer, 2014, 2015, 2022
Fellow, American Physiological Society, 2019
Impact Award (Midcareer award) American Physiological Society, 2020
Fellow, Gerontological Society of America, 2021
Merrick Award for Outstanding Medical Research, OMRF, 2022
Associate Editor and Deputy Editor in Chief, Journal of Applied Physiology, 2014-2023
NIH Ad hoc review, 2016-present
NIH Standing Study Section: Aging Systems and Geriatrics, 2017-2021
Oklahoma City Nathan Shock Center Co-Director
Associate Editor, GeroScience, 2020-present
Associate Editor, Journals of Gerontology Series A, Biological Sciences, 2021-present
American Physiological Society Finance Committee, 2021-present
American Aging Society Board of Directors, 2021-present
American Aging Society President Elect, 2023
Fellow, American Physiological Society, 2018-present
American Aging Association, 2019-present
Fellow, American Gerontological Society, 2007-present
Joined OMRF’s scientific staff in 2018
Batterson PM, McGowan EM, Borowik AK, Kinter MT, Miller BF, Newsom SA, Robinson MM. High-fat diet increases electron transfer flavoprotein synthesis and lipid respiration in skeletal muscle during exercise training in female mice. Physiol Rep 11:e15840, 2023 October, PMID: 37857571, PMCID: PMC10587055
Deberneh HM, Abdelrahman DR, Verma SK, Linares JJ, Murton AJ, Russell WK, Kuyumcu-Martinez MN, Miller BF, Sadygov RG. A large-scale LC-MS dataset of murine liver proteome from time course of heavy water metabolic labeling. Sci Data 10:635, 2023 September, PMID: 37726365, PMCID: PMC10509199
Long DE, Mantuano AJ, Confides AL, Miller BF, Kern PA, Butterfield TA, Dupont-Versteegden EE. Short-term repeated human biopsy sampling contributes to changes in muscle morphology and higher outcome variability. J Appl Physiol (1985), 2023 September, PMID: 37705447
Abbott CB, Lawrence MM, Kobak KA, Lopes EBP, Peelor FF 3rd, Donald EJ, Van Remmen H, Griffin TM, Miller BF. A Novel Stable Isotope Approach Demonstrates Surprising Degree of Age-Related Decline in Skeletal Muscle Collagen Proteostasis. Function (Oxf). 2021 May 10;2(4):zqab028. doi: 10.1093/function/zqab028. eCollection 2021. PMID: 34124684, PMCID: PMC8187230
Wolff CA, Lawrence MM, Porter H, Zhang Q, Reid JJ, Laurin JL, Musci RV, Linden MA, Peelor FF 3rd, Wren JD, Creery JS, Cutler KJ, Carson RH, Price JC, Hamilton KL, Miller BF. Sex differences in changes of protein synthesis with rapamycin treatment are minimized when metformin is added to rapamycin. Geroscience. 2020 Aug 5. Epub ahead of print. PMID: 32761290, PMCID: PMC8110668
Miller BF, Reid JJ, Price JC, Lin HL, Atherton PJ, Smith K. CORP: The use of deuterated water for the measurement of protein synthesis. J Appl Physiol (1985). 2020;128(5):1163-1176. PMID: 32213116
Konopka AR, Laurin JL, Schoenberg HM, Reid JJ, Castor WM, Wolff CA, Musci RV, Safairad OD, Linden MA, Biela LM, Bailey SM, Hamilton KL, Miller BF. Metformin inhibits mitochondrial adaptations to aerobic exercise training in older adults. Aging Cell. 2019 Feb;18(1):e12880. PMID: 30548390, PMCID: PMC6351883
Miller BF, Drake JC, Naylor B, Price JC, Hamilton KL. The measurement of protein synthesis for assessing proteostasis in studies of slowed aging. Ageing Res Rev. 2014 Nov;18:106-11. PMID: 25283966, PMCID: PMC4258117
Aging & Metabolism Research Program, MS 21
Oklahoma Medical Research Foundation
825 N.E. 13th Street
Oklahoma City, OK 73104
Phone: (405) 271-7767 or (405) 271-7760
Fax: (405) 271-1437
Christiana Raymond-Pope, Ph.D.
Assistant Staff Scientist
Agnieszka Borowik, Ph.D.
Matthew Bubak, Ph.D.
Jordan Fuqua, Ph.D.
Paulo Mesquita, Ph.D.
Colleen O'Reilly, Ph.D.
Frederick "Rick" Peelor
Assistant Laboratory Manager
Research Technician II
Research Technician II
Project Coordinator II
News from the Miller lab
2020 had many downsides. But for Dr. Benjamin Miller, a year devoid of social engagements and work-related travel brought an unexpected gift: more time on his bike. A former elite amateur cyclist, Miller gets up before dawn most mornings to ride. He estimates he spends 10 to 15 hours cycling in a typical week, which […]